Published in Int J Chron Obstruct Pulmon Dis on September 07, 2010
The evidence on tiotropium bromide in asthma: from the rationale to the bedside. Multidiscip Respir Med (2017) 1.39
Aclidinium inhibits human lung fibroblast to myofibroblast transition. Thorax (2011) 0.96
Pulmonary fibroblasts mobilize the membrane-tethered matrix metalloprotease, MT1-MMP, to destructively remodel and invade interstitial type I collagen barriers. Am J Physiol Lung Cell Mol Physiol (2011) 0.91
Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects. Mediators Inflamm (2012) 0.87
mAChRs activation induces epithelial-mesenchymal transition on lung epithelial cells. BMC Pulm Med (2014) 0.85
Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung. J Cell Mol Med (2012) 0.83
Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae. Respir Res (2012) 0.80
Involvement of Toll-like receptor 2 and epidermal growth factor receptor signaling in epithelial expression of airway remodeling factors. Am J Respir Cell Mol Biol (2015) 0.76
Suppression of type I collagen in human scleral fibroblasts treated with extremely low-frequency electromagnetic fields. Mol Vis (2013) 0.76
Non-Smad TGF-beta signals. J Cell Sci (2005) 6.06
Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol (1995) 3.39
New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol (2009) 2.34
The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.23
Matrix metalloproteinases in destructive pulmonary pathology. Thorax (2005) 2.06
Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med (2001) 1.98
Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest (1998) 1.97
Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med (2001) 1.96
Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc (2004) 1.87
TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch. EMBO J (2008) 1.74
Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis (1988) 1.68
Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression. Chest (2007) 1.62
M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.49
Models of chronic obstructive pulmonary disease. Respir Res (2004) 1.42
MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2000) 1.33
Involvement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular matrix accumulation. J Biol Chem (2004) 1.32
Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol (2005) 1.27
Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med (2005) 1.20
Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1995) 1.10
Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res (2005) 1.07
Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis. Pulm Pharmacol Ther (2006) 1.06
Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med (1996) 1.06
TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes. J Immunol (2003) 1.02
TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Med Wkly (2009) 1.02
TGF-beta-induced Ca(2+) influx involves the type III IP(3) receptor and regulates actin cytoskeleton. Am J Physiol Renal Physiol (2002) 1.01
Decorin and TGF-beta1 polymorphisms and development of COPD in a general population. Respir Res (2006) 0.98
Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J Korean Med Sci (2003) 0.97
Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J (2008) 0.95
In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats. Eur J Pharmacol (2004) 0.94
MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Respir Med (2008) 0.94
Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon. Neurogastroenterol Motil (2004) 0.91
Inflammation and remodeling in chronic obstructive pulmonary disease. J Allergy Clin Immunol (2004) 0.88
Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro. Int J Chron Obstruct Pulmon Dis (2008) 0.86
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Treat Respir Med (2004) 0.83
Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol (2010) 0.83
Usefulness of cholescintigraphy with lipid meal loading for diagnosis and determination of cholecystectomy in a patient with gallbladder dysfunction. Intern Med (2004) 1.39
The Japanese Respiratory Society guidelines for management of cough. Respirology (2006) 1.13
Antiinflammatory role of MUC1 mucin during infection with nontypeable Haemophilus influenzae. Am J Respir Cell Mol Biol (2012) 1.06
Examination, diagnosis and classification for Japanese allergic rhinitis: Japanese guideline. Auris Nasus Larynx (2012) 0.94
Novel mutations of the FASN gene and their effect on fatty acid composition in Japanese Black beef. Biochem Genet (2009) 0.93
Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner. Exp Dermatol (2012) 0.92
Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro. J Pharm Pharmacol (2006) 0.91
Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection. J Gastroenterol Hepatol (2007) 0.89
Involvement of Toll-like receptors in the immune response of nasal polyp epithelial cells. Clin Immunol (2007) 0.88
Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro. Int J Chron Obstruct Pulmon Dis (2008) 0.86
Typical carcinoid tumor arising in the nose and paranasal sinuses--case report. Auris Nasus Larynx (2009) 0.85
Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. Mediators Inflamm (2003) 0.85
Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro. Mediators Inflamm (2005) 0.85
Reliability and validity assessments of a Japanese version of QOL 20-Item Sino-Nasal Outcome Test for chronic rhinosinusitis. Auris Nasus Larynx (2010) 0.85
Induction of apoptosis in nasal polyp fibroblasts by glucocorticoids in vitro. Acta Otolaryngol (2003) 0.84
Astaxanthin attenuates the UVA-induced up-regulation of matrix-metalloproteinase-1 and skin fibroblast elastase in human dermal fibroblasts. J Dermatol Sci (2010) 0.84
Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol (2010) 0.83
Epinastine hydrochloride antagonism against interleukin-4-mediated T cell cytokine imbalance in vitro. Int Arch Allergy Immunol (2006) 0.82
Practical capability and cost effectiveness of a DNA pool-based genome-wide association study using BovineSNP50 array in a cattle population. Anim Sci J (2012) 0.82
Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro. Mediators Inflamm (2004) 0.82
Influence of fluticasone propionate on the production of vascular endothelial growth factor and basic fibroblast growth factor from nasal fibroblasts in vitro. In Vivo (2005) 0.81
Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro. Acta Otolaryngol (2004) 0.81
Mechanism of salivary secretion enhancement by Byakkokaninjinto. Biol Pharm Bull (2008) 0.81
Suppressive activity of epinastine hydrochloride on TARC production from human peripheral blood CD4+ T cells in-vitro. J Pharm Pharmacol (2005) 0.80
[Effects of concurrent S-1, nedaplatin/radiation therapy for 5 cases of head and neck cancer with esophageal carcinoma]. Gan To Kagaku Ryoho (2010) 0.80
Structural changes of the airway wall impair respiratory function, even in mild asthma. Chest (2002) 0.80
Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. Auris Nasus Larynx (2011) 0.79
Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo. J Pharm Pharmacol (2007) 0.79
Suppression of IL-8 production from airway cells by tiotropium bromide in vitro. Int J Chron Obstruct Pulmon Dis (2011) 0.78
Transforming growth factor alpha protects against Fas-mediated liver apoptosis in mice. FEBS Lett (2002) 0.78
Expression of antiviral molecular genes in nasal polyp-derived cultured epithelial cells. Acta Otolaryngol Suppl (2009) 0.78
Enhancement of clara cell 10-kD protein (CC10) production from nasal epithelial cells by fexofenadine hydrochloride. Asian Pac J Allergy Immunol (2012) 0.78
Nonsuppurative myocarditis caused by porcine circovirus type 2 in a weak-born piglet. J Vet Med Sci (2005) 0.78
Mediastinal lung herniation associated with pulmonary sequestration. J Thorac Imaging (2007) 0.78
Glucocorticoid receptor immunoreactivity of eosinophils in nasal polyps. Acta Otolaryngol Suppl (2009) 0.78
Suppressive activity of fexofenadine hydrochloride on the production of eosinophil chemoattractants from human nasal fibroblasts in vitro. Arzneimittelforschung (2004) 0.77
Suppressive activity of macrolide antibiotics on nitric oxide production from nasal polyp fibroblasts in vitro. Acta Otolaryngol (2003) 0.77
Clinical outcomes of ventilation tube placement in children with cleft palate. Int J Pediatr Otorhinolaryngol (2012) 0.77
Suppressive activity of fexofenadine hydrochloride on thymus- and activation-regulated chemokine production from human peripheral blood leukocytes in response to antigenic stimulation in vitro. Int Arch Allergy Immunol (2004) 0.77
Suppressive activity of vitamin D3 on matrix metalloproteinase production from cholesteatoma keratinocytes in vitro. Mediators Inflamm (2005) 0.77
Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid. In Vivo (2008) 0.77
Glycomics of a novel type-2 N-acetyllactosamine-specific lectin purified from the feather star, Oxycomanthus japonicus (Pelmatozoa: Crinoidea). Comp Biochem Physiol B Biochem Mol Biol (2010) 0.77
Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro. In Vivo (2008) 0.76
Double-stranded RNA poly(I:C) enhances matrix metalloproteinase mRNA expression in human nasal polyp epithelial cells. Acta Otolaryngol Suppl (2009) 0.76
[Study on difference in olfactory response in dysosmia patients]. Nihon Jibiinkoka Gakkai Kaiho (2002) 0.76
[Analysis of the risk factors for severe neutropenia in advanced non-small cell lung cancer after the first course of chemotherapy with third-generation agents]. Yakugaku Zasshi (2013) 0.76
Abrogating effect of N-linked carbohydrate modifiers on the stem cell factor and endothelin-1-stimulated epidermal pigmentation in human epidermal equivalents. J Dermatol Sci (2012) 0.76
Comparison of physicians' compliance, clinical efficacy, and drug cost before and after introduction of Asthma Prevention and Management Guidelines in Japan (JGL2003). Allergol Int (2010) 0.76
Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2. World J Gastroenterol (2006) 0.76
High free serum acrolein levels in bacterial infection and other disease states associated with oxidative stress: a potential biomarker? Clin Chem Lab Med (2007) 0.76
Suppression of nitric oxide production from nasal fibroblasts by metabolized clarithromycin in vitro. J Inflamm (Lond) (2010) 0.76
Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo. Mediators Inflamm (2002) 0.75
Influence of epinastine hydrochloride, an H1-receptor antagonist, on the function of mite allergen-pulsed murine bone marrow-derived dendritic cells in vitro and in vivo. Mediators Inflamm (2009) 0.75
Enhancement of thioredoxin production from nasal epithelial cells by the macrolide antibiotic, clarithromycin in vitro. In Vivo (2013) 0.75
[Effectiveness of concomitant therapy with S-1, nedaplatin, and radiation for laryngeal cancer]. Gan To Kagaku Ryoho (2010) 0.75
[Clinical study of smoking cessation clinic subjects]. Nihon Jibiinkoka Gakkai Kaiho (2011) 0.75
Prognostic Index for Survival in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Third-Generation Agents. Chemotherapy (2017) 0.75
[Odor stick identification test for Japanese patients with olfactory disturbances]. Nihon Jibiinkoka Gakkai Kaiho (2006) 0.75
Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis. Int Forum Allergy Rhinol (2014) 0.75
Palatoplasty and growth of the temporal bone mastoid air cells. Cleft Palate Craniofac J (2011) 0.75
[Combination steroid and hyperbaric oxygenation therapy for sudden idiopathic sensorineural hearing loss]. Nihon Jibiinkoka Gakkai Kaiho (2007) 0.75
Suppressive effect of fluticasone propionate on MMP expression in the nasal mucosa of allergic rhinitis patients in vivo. In Vivo (2006) 0.75
Severe manifestation of acute hepatitis A recently found in Gunma, Japan. J Gastroenterol (2002) 0.75
[Serum amyloid protein A was a useful marker for steroid tapering in a case of MPO-ANCA-associated vasculitis]. Nihon Kokyuki Gakkai Zasshi (2005) 0.75
Modulation of eosinophil survival by epinastine hydrochloride, an H1 receptor antagonist, in vitro. In Vivo (2009) 0.75
[Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer]. Gan To Kagaku Ryoho (2010) 0.75
[Long-term effect of roxithromycin on NO production]. Jpn J Antibiot (2003) 0.75
[A case of a slow-growing, non-mucin-producing bronchioloalveolar carcinoma with a 9-year clinical history before thoracoscopic surgery]. Nihon Kokyuki Gakkai Zasshi (2004) 0.75
The decreased secretion of hyaluronan by older human fibroblasts under physiological conditions is mainly associated with the down-regulated expression of hyaluronan synthases but not with the expression levels of hyaluronidases. Cytotechnology (2014) 0.75
[Acute onset of somnolence and amnesia due to cerebral infarction of bilateral thalamus accompanied with tuberculous meningitis: a case report]. Kekkaku (2004) 0.75
[Suppressive effect of roxithromycin on NO production in fibroblasts of human nasal mucosa]. Jpn J Antibiot (2003) 0.75
[Guidelines in macrolide therapy for children with suppurative otitis media]. Jpn J Antibiot (2003) 0.75
Orthopedic treatment of metastatic bone fracture from hepatocellular carcinoma. Hepatogastroenterology (2002) 0.75
[Effectiveness of simultaneous combination therapy using S-1, nedaplatin and radiotherapy for 7 cases of oropharynx cancer]. Gan To Kagaku Ryoho (2010) 0.75
[Three cases of adenocarcinoma of the head and neck maintaining QOL by administration of docetaxel]. Gan To Kagaku Ryoho (2010) 0.75
Paracrine cytokine mechanisms underlying the hyperpigmentation of seborrheic keratosis in covered skin areas. J Dermatol (2013) 0.75
[Suppressive effect of roxithromycin on co-stimulatory molecule expression]. Jpn J Antibiot (2003) 0.75
[Case of acute respiratory distress syndrome treated with direct hemoperfusion using a polymyxin B immobilized fiber colum]. Nihon Kokyuki Gakkai Zasshi (2008) 0.75
[The effectiveness of concomitant radiotherapy with S-1 and nedaplatin for tongue cancer]. Gan To Kagaku Ryoho (2009) 0.75
Evidence for passing down of postnasal drip into respiratory organs. In Vivo (2009) 0.75
[A case of spontaneous epidural emphysema occurring during sleep]. Nihon Kokyuki Gakkai Zasshi (2006) 0.75
Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps. Acta Otolaryngol Suppl (2004) 0.75
[Case of primary cavitary sarcoidosis: exacerbation after 16 years from onset]. Nihon Kokyuki Gakkai Zasshi (2006) 0.75
[Effect of roxithromycin on inflammatory cytokine production in nasal polyp fibroblasts]. Jpn J Antibiot (2003) 0.75
The effect of a glucocorticoid on olfactory response of isolated mouse olfactory cells. In Vivo (2003) 0.75
Pulmonary adenocarcinoma complicated with pulmonary infarction presented as intrapulmonary metastases: a report of a case. Ann Thorac Cardiovasc Surg (2006) 0.75
Withaferin A abolishes the stem cell factor-stimulated pigmentation of human epidermal equivalents by interrupting the auto-phosphorylation of c-KIT in human melanocytes. Arch Dermatol Res (2014) 0.75
[CPT-11 chemotherapy for a hemodialysis patient with small-cell lung cancer]. Gan To Kagaku Ryoho (2011) 0.75
[Two cases of head and neck squamous cell carcinoma in which S-1 administration resulted in long-term sustained QOL]. Gan To Kagaku Ryoho (2009) 0.75
[A case of Mycobacterium abscessus pulmonary infection; effectiveness of clarithromycin, amikacin and imipenem/cilastatin]. Nihon Kokyuki Gakkai Zasshi (2006) 0.75
[Efficacy of concurrent chemoradiotherapy in cases with cervical lymph node metastasis from oropharyngeal or hypopharyngeal cancer]. Gan To Kagaku Ryoho (2011) 0.75